Trial intelligence / Profile preview

Adhesiolysis Modalities for Complex Pleural Effusion

NCT03172052Phase 4Unknown

Sponsor
Assiut University
Start
Aug 2017
Primary completion
Jun 2019
Modality
Recombinant Proteins and Enzymes, Small Molecules
01

Overview

Phase 4, randomised, open-label trial of streptokinase and mesna in pleural effusion (4 arms), sponsored by Assiut University. Primary endpoint: measurement of adhesiolysis success at 28 days. Status: unknown.

02

Drugs

streptokinasemesna
03

Conditions

pleural effusion

Beyond the preview

Go deeper on NCT03172052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03172052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call